Select Medical (NYSE:SEM) Downgraded by TheStreet

Select Medical (NYSE:SEM) was downgraded by TheStreet from a “b-” rating to a “c+” rating in a report released on Friday, February 2nd.

A number of other research analysts also recently issued reports on the company. Zacks Investment Research downgraded Select Medical from a “hold” rating to a “sell” rating in a research note on Saturday, February 3rd. ValuEngine upgraded Select Medical from a “hold” rating to a “buy” rating in a research note on Friday, February 2nd. Wells Fargo & Co began coverage on Select Medical in a research note on Tuesday, January 30th. They set an “outperform” rating and a $26.00 price target on the stock. Bank of America upgraded Select Medical from an “underperform” rating to a “neutral” rating and set a $19.00 price target on the stock in a research note on Thursday, January 4th. Finally, Deutsche Bank restated a “buy” rating and set a $22.00 price target on shares of Select Medical in a research note on Monday, November 6th. Two research analysts have rated the stock with a sell rating, two have issued a hold rating and six have given a buy rating to the company’s stock. Select Medical has an average rating of “Hold” and a consensus target price of $20.25.

Shares of Select Medical (SEM) opened at $16.50 on Friday. The firm has a market capitalization of $2,221.49, a PE ratio of 21.01, a PEG ratio of 1.04 and a beta of 1.30. The company has a debt-to-equity ratio of 3.36, a quick ratio of 1.51 and a current ratio of 1.51. Select Medical has a 12-month low of $12.00 and a 12-month high of $19.77.

In other Select Medical news, insider Martin F. Jackson sold 134,029 shares of Select Medical stock in a transaction that occurred on Friday, December 22nd. The stock was sold at an average price of $17.05, for a total value of $2,285,194.45. Following the transaction, the insider now directly owns 1,717,944 shares in the company, valued at approximately $29,290,945.20. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Scott A. Romberger sold 5,000 shares of Select Medical stock in a transaction that occurred on Wednesday, November 29th. The shares were sold at an average price of $17.97, for a total value of $89,850.00. Following the completion of the transaction, the insider now owns 168,211 shares in the company, valued at $3,022,751.67. The disclosure for this sale can be found here. Insiders sold a total of 295,955 shares of company stock worth $5,052,199 over the last quarter. Company insiders own 19.93% of the company’s stock.

Institutional investors have recently bought and sold shares of the stock. PNC Financial Services Group Inc. boosted its stake in shares of Select Medical by 4.8% in the second quarter. PNC Financial Services Group Inc. now owns 8,709 shares of the health services provider’s stock valued at $133,000 after buying an additional 396 shares in the last quarter. Flinton Capital Management LLC boosted its stake in shares of Select Medical by 75.8% in the second quarter. Flinton Capital Management LLC now owns 9,744 shares of the health services provider’s stock valued at $150,000 after buying an additional 4,200 shares in the last quarter. Shelton Capital Management purchased a new stake in shares of Select Medical in the second quarter valued at approximately $164,000. Eqis Capital Management Inc. purchased a new stake in shares of Select Medical in the third quarter valued at approximately $201,000. Finally, Amalgamated Bank boosted its stake in shares of Select Medical by 2.6% in the second quarter. Amalgamated Bank now owns 14,806 shares of the health services provider’s stock valued at $227,000 after buying an additional 376 shares in the last quarter. Hedge funds and other institutional investors own 78.09% of the company’s stock.

ILLEGAL ACTIVITY NOTICE: “Select Medical (NYSE:SEM) Downgraded by TheStreet” was first reported by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are viewing this piece of content on another domain, it was illegally copied and republished in violation of United States and international copyright and trademark legislation. The correct version of this piece of content can be accessed at https://www.dispatchtribunal.com/2018/02/13/select-medical-sem-stock-rating-lowered-by-thestreet.html.

About Select Medical

Select Medical Holdings Corporation is an operator of specialty hospitals, outpatient rehabilitation clinics and occupational medicine centers in the United States. The Company’s segments include specialty hospitals, outpatient rehabilitation, Concentra and Other. The specialty hospitals segment consists of hospitals designed to serve the needs of long term acute patients and hospitals designed to serve patients that require intensive medical rehabilitation care.

Analyst Recommendations for Select Medical (NYSE:SEM)

Receive News & Ratings for Select Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Select Medical and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply